INNOVATIVE THERAPIES BASED ON A NEXT-GENERATION DRUG DELIVERY PLATFORM

About Us

At MDimune, we are passionate about changing the world by developing innovative therapeutics.

History

FOUNDATION ~ 2020
2020
05
  • Certified for Advanced Technology and Producs by the Ministry of Trade, Industry and Energy
04
  • INNO-Biz certification by the Small and Medium Business Administration
03
  • Acquired a U.S. patent on BioDrone® platform technology
01
  • Signed a joint development agreement with Ildong Pharmaceutical Co Ltd for anticancer drug based on BioDrone® technology
2019
12
  • Certified for the Excellence in Employee Invention Promotion by the Korean Intellectual Property Office
  • Signed an investment contract with DB Financial Investment
08
  • Designated DB Financial Investment as an IPO underwriter
06
  • Signed an investment contract with The Wells Investment
05
  • Received investments from institutional investors (QUAD Investment Management, STIC VENTURES, KCLAVIS Investment, DAYLI Partners, InterValue Partners)
02
  • Recruited Dr. Seung Wook Oh as a Chief Scientific Officer
01
  • Awarded a Youth-friendly Enterprise certification by the Ministry of Employment and Labor
2018
12
  • Awarded a Post-TIPS (Tech Incubator Program for Startup) grant and Global Marketing grant
05
  • Signed investment contract with STIC Investments Inc.
  • Selected as a designated company for alternative military services by Seoul Regional Military Manpower Administration
04
  • Selected for an Exclusive Consultant Support project for Innovative Biotherapeutics R&D by Korea Food and Drug Administration
03
  • Awarded the grand prize for the biotech division of the Korea Industrial Enterprise Award by Money Today for the second consecutive year
  • Signed investment contracts with The Wells Investment, Invest Korea, LNS Venture, and InterValue Partners
2017
12
  • Signed a joint development agreement with Institute for Refractory Cancer Research at Samsung Medical Center for brain cancer therapeutics
11
  • Signed a joint development agreement with Hypoxia-related Disease Research Center at Inha University Medical School for brain disease therapeutics
03
  • Received the grand prize for the biotech division of the Korea Industrial Enterprise Award by Money Today
  • Signed a business agreement with KBIO Center for New Drug Development at Osong
2016
10
  • Relocated the headquarters and research center
09
  • Awarded a TIPS (Tech Incubator Program for Startup) grant by the Small and Medium Business Administration
  • Selected for an Investors-linked R&D project by Ministry of Trade, Industry and Energy
08
  • Received investments, including Institutional Investors
05
  • Launched an MDimune R&D center under Korea Industrial Technology Association
03
  • Selected for TIPS (Tech Incubator Program for Startup) by the Small and Medium Business Administration
  • Signed investment contract with Innopolis Partners, LLC
2015
10
  • Certified as a venture company by Korea Technology Finance Corporation
05
  • Signed a technology transfer agreement, “Proprietary drug delivery technology based on artificial exosome”
04
  • Founded MDimune Inc.

Certification Status

/
/
trademark registration
DDS4.0
(the United States of America)
상표등록
엠디뮨
(대한민국)
상표등록
DDS4.0
(대한민국)
商標登録
BioDrone
(日本)
trademark registration
BioDrone
(the United States of America)
상표등록
BioDrone
(대한민국)
상표등록
바이오드론
(대한민국)
상표등록
Bionanosome
(대한민국)
/
첨단기술·제품 확인서
(산업통상자원부)
기술혁신형 중소기업 확인서
(중소벤처기업부)
직무발명보상 우수기업 인증
(특허청)
벤처기업확인서
(한국벤처캐피탈협회)
중소기업확인서
(중소벤처기업부)
청년친화강소기업 우수
(고용노동부)
인재육성형 중소기업 지정서
(중소벤처기업부)
청년재직자
내일채움공제가입증서
(중소기업진흥공단)
청년내일채움공제가입증서
(중소기업진흥공단)
기업부설연구소인정서
(한국산업기술진흥협회)
2018대한민국 산업대상
바이오부분 2년연속 대상
(머니투데이)
2017대한민국 산업대상
바이오부분 대상
(머니투데이)
상표등록
DDS4.0
(미국)
상표등록
엠디뮨
(대한민국)
상표등록
DDS4.0
(대한민국)
상표등록
BioDrone
(일본)
상표등록
BioDrone
(미국)
상표등록
BioDrone
(대한민국)
상표등록
바이오드론
(대한민국)
상표등록
Bionanosome
(대한민국)